Codes / ICD10CM / T36.5X2S

T36.5X2S Poisoning by aminoglycosides, intentional self-harm, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by aminoglycosides, intentional self-harm, sequela

Summary

This condition represents the residual effects of intentional self-harm poisoning by aminoglycosides. It applies when the initial poisoning event has resolved, but long-term consequences persist. Documentation should specify the type of aminoglycoside, the intentional nature of the prior exposure, and details of the residual effects.

Causes

Sequela result from prior intentional self-harm involving aminoglycosides, such as deliberate overdose or ingestion. The residual effects may stem from cumulative toxicity, organ damage, or persistent adverse reactions that persist after the acute event.

Risk Factors

  • Prior history of aminoglycoside toxicity or renal impairment.
  • Psychiatric conditions increasing self-harm risk.
  • Access to aminoglycosides in clinical or home settings.
  • Prior suicide attempts or ideation.
  • Lack of supervision in at-risk populations.

Symptoms

  • Persistent renal dysfunction (e.g., chronic kidney disease).
  • Permanent ototoxicity (e.g., hearing loss, vestibular damage).
  • Neurological deficits (e.g., persistent weakness, neuropathy).
  • Gastrointestinal complications (e.g., chronic pain, malabsorption).
  • Psychological sequelae (e.g., depression, anxiety).

Diagnosis

Evaluation includes clinical assessment of residual symptoms, review of prior poisoning history, and targeted testing (e.g., renal function, audiometry, neurological exams). Imaging or specialized tests may be used to assess organ damage.

Treatment Options

Management focuses on addressing residual effects, such as renal replacement therapy for chronic kidney disease, hearing aids or vestibular rehabilitation for ototoxicity, and supportive care for neurological or psychological symptoms. Rehabilitation and counseling may be indicated.

Prognosis and Follow-Up

Prognosis depends on the severity of residual damage. Regular follow-up is essential to monitor organ function, adjust treatments, and address psychological needs. Long-term care may be required for irreversible sequelae.

Complications

  • Progressive renal failure.
  • Permanent hearing loss or balance disorders.
  • Chronic neurological impairment.
  • Psychological distress or suicidal ideation.
  • Reduced quality of life due to persistent symptoms.

Lifestyle & Prevention

  • Adherence to prescribed medications and monitoring.
  • Avoidance of further self-harm behaviors.
  • Regular health check-ups to manage residual effects.
  • Psychological support and therapy.
  • Education on medication safety and risk reduction.

When to Seek Professional Help

Seek immediate care for new or worsening symptoms (e.g., severe pain, confusion, or organ dysfunction). Ongoing care is needed for persistent sequelae, and mental health support is critical for those at risk of self-harm.

Tips for Medical Coders

Document the type of aminoglycoside, the intentional nature of the prior self-harm, and the specific residual effects. Ensure the sequela are clearly linked to the prior poisoning event. Use additional codes for acute episodes or unrelated conditions as needed.

Book a walkthrough

T36.5X2S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.